Allied Pharma Technologies’ Post

Welcome to the team, Lyptus! For further information on how Lyptus workforce solutions can help you to achieve your goals, speak to Paul Chiswick

If you are part of NSN, please join our upcoming virtual discussion on how to close your year strong! Derrick Knox and Brad Townsend are two of the best leaders in the business and have a wealth of knowledge to share on this topic. #GEHealthCare

Set yourself up for success

Is it too soon to start thinking about Christmas and the end of 2024? We are putting up our Christmas tree in the office this week and finalising the food order for our Company Christmas dinner, so at Oxford Biosystems we are certainly getting in the Christmas spirit! But, before we start our celebrations, we should also take time to reflect on the past year. Like many companies, especially the smaller companies and not only those in our industry, we have found 2024 has been another challenging year. We work in a market that has seen many changes since the start of the pandemic. We also see the challenges brought by legislation in our industry – the changes required to products to meet IVDR requirements, the need for MHRA registration and the start of the UKCA requirements. As a distributor, we greatly appreciate the ongoing support of our Suppliers across the world. The business relationships we have built with all of them are stronger than ever and we are looking forward to another great year in 2025. Our wonderful team at Oxford Biosystems has met all our challenges this year with enthusiasm and amazing team spirit. We continue to grow and will be using time in December to plan ahead for 2025 and beyond – in between the festivities of course! If you would like more information about any of our products please visit our website or contact us directly to discuss your requirements. www.oxfordbiosystems.com #Diagnostics #IVDR #IBLInternational #Alifax #ViennaLab #Biovendor #Diasource #Biomedica #SSIDiagnostica #Quansys #SDBiosensor #Hygiena #Aidian #Testline #Mediagnost #Kamiya #Euroclone #OBS #OxfordBioSystems

Are you a healthcare professional interested in learning about growth efficiency? ByHeart is hosting a free webinar, “Advances in Infant Formula Science: Focus on Growth Efficiency,” where we’ll explore the impacts of early infant nutrition on metabolic programming. We're offering multiple sessions to accommodate your busy schedules. Register for an upcoming lunch & learn below!

Haven't signed up for ByHeart's free webinar, “Advances in Infant Formula Science: Focus on Growth Efficiency”? Come lunch and learn while we discuss the impacts of early infant nutrition on metabolic programming. Register for an upcoming session below!

🚀 Exciting News! We’re Thrilled to Announce Our New Partnership with Aurobindo Pharma USA, Inc.! 🚀 We’re proud to partner with Aurobindo to bring their employees exclusive savings through Previ! 🎉 Here’s the deal: Previ empowers employees to save $1,200+ per year on essential services like T-Mobile and AT&T cell phone service— while providing them premium and unlimited plans. Better plans and less 💸. 👉 What’s in it for Aurobindo USA? ✔️ $0 cost to the company ✔️ No hidden fees, no complicated terms—just straightforward savings ✔️ Easy implementation with full support from the Previ team Through this partnership, Aurobindo USA is taking a proactive step in enhancing their employees’ financial wellness without any extra cost. 💼🙌 We can’t wait to see the impact of these savings for their teams! 💪 Stay tuned for more updates as we continue to help companies bring financial benefits that really make a difference.

I have had a great day at the Health Innovation West of England annual conference. It was lovely to catch-up with colleagues from across the system both old and new. A few of my key takeaways and reflections... 💡 1. Now more than ever the NHS needs innovation, but innovative solutions will only work and thrive if they solve an articulated and evidenced problem. 2. The path for innovators in the NHS is often long, cyclical and unnecessarily complex. Work needs to be done to create a consistent and clear path across NHS organisations that enables the adoption of innovation rather than stifling it. 3. There is consensus that we need to get better at articulating the value of innovation, so that we can measure impact and create meaningful sustainable change.

Thought-provoking and humorous campaigns that pushed vaccine awareness and uptake, and those that sought to convey an inside look at how patients feel as they face various conditions – from physically painful ones such as generalized pustular psoriasis, to the emotional and mental strain of alopecia areta, to an inside look at how your dog with osteoarthritis really feels – were the leaders that made the cut on the 2024 Outcomes Creativity Index (OCI). #healthcaremarketing #healthcareadvertising #pharmamarketing #pharmaceuticalmarketing #MedAdNews

Coloplast is at the BAUN Conference in Liverpool today. We hope to see you on stand 21 for you to discover more about Micro-hole Zone Technology and our next generation catheter, Luja. Luja ensures complete bladder emptying in a free flow and addresses more catheter-related UTI risk factors than ever before*. We're also hosting a symposium on transforming ideas into clinical outcomes, at 16:15, in room 11. *Complete bladder emptying is defined as <10 mL (NCT05485922, N=42). Individual results may vary. UTI risk factors defined by Kennelly M., et al. (2019)